Dab2, a negative regulator of DC immunogenicity, is an attractive molecular target for DC-based immunotherapy

Md Selim Ahmed, Se Eun Byeon, Yideul Jeong, Mohammad Alam Miah, Md Salahuddin, Yoon Lee, Sung Soo Park, Yong Soo Bae

Research output: Contribution to journalArticlepeer-review

26 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Dab2, a negative regulator of DC immunogenicity, is an attractive molecular target for DC-based immunotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences